Equip yourself with state-of-the-art knowledge relating to the mechanisms of chronic disease progression. Learn how these underlying causes are targeted therapeutically and discover the technologies helping to detect and diagnose the chosen disease specialism.
This MSc is designed to directly meet research demands in the NHS, industry and academia where there is a need for scientists with both biological knowledge and the computational, statistical, analytical, and practical skills to drive precision medicine. Be a part of the next generation of scientists responsible for creating new diagnostic tests and new tailored therapies to aid earlier diagnosis and optimal treatment for patients suffering from cancer, cardiovascular or inflammatory disease. Seminars from world class leaders in field from around the world, including academics, industry experts, and NHS experts (e.g. Professor Calum MacRae, Ken Sutherland, Harper van Steenhouse, David Brunton, Marian McNeil, Claire Orange, Prof Dame Dominiczak, Prof Andrew Biankin, Professor Iain McInnes, etc) Gain skills and experience to allow you to become an outstanding researcher in this field, working towards pre-emptive, predictive, personalised and participatory medicine. Be part of developing new diagnostic tests and new tailored therapies to aid earlier diagnosis and optimal treatment for patients suffering from cancer, cardiovascular disease or inflammatory disease. Expand your understanding of these diseases to enable the identification of the molecular causes and ultimately support the development of novel, more precisely targeted treatments in these areas. Utilise cutting-edge facilities, research and teaching experience at the University of Glasgow and Queen Elizabeth University Hospital.
This programme will provide an excellent background for those looking to establish a career in biomedical research in academia, biotechnology and pharmaceutical industries in the precision medicine field and clinical sciences in the NHS. Other opportunities lie in the area of clinical trials and research management.